Insider selling
Traded Nov 24, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
The CEO of Chemed sold $875K of Chemed shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 10, 2025
16 tracked managers disclosed the same change for Q3 2025. From a 13F filed Nov 10, 2025 covering holdings at Sep 30, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q2 2025 13F
69,563
61,974
−10.9%
Share count drives classification; reported value also moves with price
0.24%
Within the filing's reported positions, not the manager's total assets
16
For Q3 2025
Insider selling
Traded Nov 24, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
The CEO of Chemed sold $875K of Chemed shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Nov 19, 2025 · filed the same day
Gift or transfer — classified separately from trades.
Fund moves
16 tracked managers disclosed the same change for Q3 2025. From a 13F filed Nov 13, 2025 covering holdings at Sep 30, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.